Research Status Note: Recovery Study by Dr. Sarah Cefai
Data & Methodology:
Total Sample: 75 video interviews with individuals who have recovered or achieved measured improvement from chronic illness.
Total Sample: 75 video interviews with individuals who have recovered or achieved measured improvement from chronic illness.
Cohort:
Includes 75 participants recruited from Raelan Agle’s YouTube recovery channel. A total of 63% (n = 47) had a diagnosis of ME/CFS, 31% (n = 23) had Long Covid, and just under a third (n = 23) had additional diagnoses, notably POTS.
Includes 75 participants recruited from Raelan Agle’s YouTube recovery channel. A total of 63% (n = 47) had a diagnosis of ME/CFS, 31% (n = 23) had Long Covid, and just under a third (n = 23) had additional diagnoses, notably POTS.
Methodology:
Qualitative social and cultural analysis (close reading, narrative, and thematic analysis) corroborated by bespoke computational analysis.
Qualitative social and cultural analysis (close reading, narrative, and thematic analysis) corroborated by bespoke computational analysis.
Principal investigator:
Dr. Sarah Cefai, Senior Lecturer in Gender and Cultural Studies at Goldsmiths, University of London, and Leverhulme Research Fellow 2024–25.
Dr. Sarah Cefai, Senior Lecturer in Gender and Cultural Studies at Goldsmiths, University of London, and Leverhulme Research Fellow 2024–25.
The Numbers at a Glance
75 total interviews analyzed
77% (n = 58) fully recovered / 23% (n = 17) substantially recovered and still improving
95% experienced a paradigm shift using neuroplastic approaches
85% described nervous system dysregulation in their narrative accounts
64% experienced a harmful medical encounter where they were told recovery was not possible
0% recovered via a public health program; almost all recovered outside clinical settings
Key Themes & Findings
Redefining the Illness:
The study treats ME/CFS and Long Covid as closely linked. These online interviews change the common medical narrative that fewer than 5% of people recover. Instead of seeing the illness as permanent, the community shows it is something people can face and overcome.
The Recovery Mindset:
Believing that recovery is possible acts as the primary turning point. This mindset is a physical, somatic re-orientation triggered by hearing first-hand recovery stories and finding a believable, non-permanent explanation for symptoms.
Self-Determination vs. Medical Failure:
Recovery overwhelmingly happens outside of formal medicine. Participants reject hopeless medical prognoses, become self-directed researchers, and turn to para-medical/non-medical practitioners (like coaches and somatic teachers) for care.
The Mind-Body Paradigm Shift:
A striking 95% of participants rejected the strictly biological medical model in favor of a mind-body or neuroplatic model, viewing symptoms as an interaction between biology, the nervous system, trauma, and emotion. Nervous system dysregulation was the single most prevalent concept (85%).
Identity and Self-Transformation:
Illness is described as robbing a person of their identity. True healing involves a profound self-transformation, often addressing personality types, processing trauma, setting boundaries, and undergoing an ethical reflection on how to live well.
Clinical Harm (The Nocebo Effect):
Telling patients there is "no cure" causes documented psychological distress and acts as a medical nocebo, actively worsening patient outcomes and driving them away from standard healthcare systems.
Data & Methodology:
Total Sample: 238 interviews with individuals who have recovered from chronic illness.
Total Sample: 238 interviews with individuals who have recovered from chronic illness.
Cohort:
Includes 182 participants with a medically confirmed diagnosis of either Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) or Long Covid.
Includes 182 participants with a medically confirmed diagnosis of either Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) or Long Covid.
Methodology:
AI-assisted thematic analysis.
AI-assisted thematic analysis.
Research Team:
Prof. Chris Mitchell, University of Plymouth, Dr. Ben Whalley, University of Plymouth, Dr. Will Bostock, MD, Cambridge Progressive Medicine
Prof. Chris Mitchell, University of Plymouth, Dr. Ben Whalley, University of Plymouth, Dr. Will Bostock, MD, Cambridge Progressive Medicine
Annotated Bibliography for Neuroplastic Symptoms
Updated May 1, 2026
Compiled by:
Jeffrey Axelbank, PsyD
Georgie Oldfield, MCSP
David Clarke, MD